nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ABCC1—Vinblastine—head and neck cancer	0.219	0.26	CbGbCtD
Abiraterone—ABCC1—Docetaxel—head and neck cancer	0.18	0.215	CbGbCtD
Abiraterone—CYP2D6—Hydroxyurea—head and neck cancer	0.141	0.167	CbGbCtD
Abiraterone—ALB—Fluorouracil—head and neck cancer	0.109	0.13	CbGbCtD
Abiraterone—CYP2C8—Fluorouracil—head and neck cancer	0.0843	0.1	CbGbCtD
Abiraterone—CYP2D6—Vinblastine—head and neck cancer	0.0498	0.0592	CbGbCtD
Abiraterone—CYP3A4—Vinblastine—head and neck cancer	0.0317	0.0376	CbGbCtD
Abiraterone—CYP3A4—Docetaxel—head and neck cancer	0.0261	0.031	CbGbCtD
Abiraterone—SULT2A1—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00398	0.0549	CbGpPWpGaD
Abiraterone—SULT2A1—E2F transcription factor network—CEBPA—head and neck cancer	0.00369	0.0509	CbGpPWpGaD
Abiraterone—Sudden death—Fluorouracil—head and neck cancer	0.00344	0.0398	CcSEcCtD
Abiraterone—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00317	0.0367	CcSEcCtD
Abiraterone—SULT2A1—E2F transcription factor network—XRCC1—head and neck cancer	0.003	0.0415	CbGpPWpGaD
Abiraterone—SULT2A1—Phase II conjugation—NAT2—head and neck cancer	0.0027	0.0372	CbGpPWpGaD
Abiraterone—Lymphopenia—Docetaxel—head and neck cancer	0.00248	0.0287	CcSEcCtD
Abiraterone—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00219	0.0254	CcSEcCtD
Abiraterone—SULT2A1—PPARA activates gene expression—YAP1—head and neck cancer	0.00188	0.0259	CbGpPWpGaD
Abiraterone—SULT2A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	0.00184	0.0254	CbGpPWpGaD
Abiraterone—Hepatotoxicity—Docetaxel—head and neck cancer	0.00165	0.019	CcSEcCtD
Abiraterone—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00158	0.0183	CcSEcCtD
Abiraterone—SULT2A1—Biological oxidations—NAT2—head and neck cancer	0.00158	0.0218	CbGpPWpGaD
Abiraterone—SULT2A1—E2F transcription factor network—TYMS—head and neck cancer	0.00157	0.0216	CbGpPWpGaD
Abiraterone—SULT2A1—Metapathway biotransformation—NAT2—head and neck cancer	0.00156	0.0215	CbGpPWpGaD
Abiraterone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.0015	0.0208	CbGpPWpGaD
Abiraterone—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00148	0.0171	CcSEcCtD
Abiraterone—Myocardial infarction—Vinblastine—head and neck cancer	0.00147	0.017	CcSEcCtD
Abiraterone—Chest discomfort—Docetaxel—head and neck cancer	0.00144	0.0166	CcSEcCtD
Abiraterone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00137	0.0189	CbGpPWpGaD
Abiraterone—Infestation NOS—Hydroxyurea—head and neck cancer	0.00137	0.0158	CcSEcCtD
Abiraterone—Infestation—Hydroxyurea—head and neck cancer	0.00137	0.0158	CcSEcCtD
Abiraterone—SULT2A1—Phase II conjugation—GSTM1—head and neck cancer	0.00133	0.0184	CbGpPWpGaD
Abiraterone—Cardiac failure—Fluorouracil—head and neck cancer	0.00131	0.0152	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00127	0.0147	CcSEcCtD
Abiraterone—SULT2A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.00127	0.0175	CbGpPWpGaD
Abiraterone—Fluid retention—Docetaxel—head and neck cancer	0.00121	0.014	CcSEcCtD
Abiraterone—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00114	0.0132	CcSEcCtD
Abiraterone—Angiopathy—Hydroxyurea—head and neck cancer	0.00111	0.0129	CcSEcCtD
Abiraterone—Anaemia—Vinblastine—head and neck cancer	0.00108	0.0125	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00106	0.0123	CcSEcCtD
Abiraterone—SULT2A1—PPARA activates gene expression—CYP1A1—head and neck cancer	0.00106	0.0146	CbGpPWpGaD
Abiraterone—SULT2A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.00103	0.0143	CbGpPWpGaD
Abiraterone—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00103	0.0119	CcSEcCtD
Abiraterone—Hypertension—Vinblastine—head and neck cancer	0.00101	0.0117	CcSEcCtD
Abiraterone—Pneumonia—Fluorouracil—head and neck cancer	0.00099	0.0115	CcSEcCtD
Abiraterone—Anaemia—Hydroxyurea—head and neck cancer	0.000988	0.0114	CcSEcCtD
Abiraterone—Discomfort—Vinblastine—head and neck cancer	0.000986	0.0114	CcSEcCtD
Abiraterone—Hot flush—Docetaxel—head and neck cancer	0.000986	0.0114	CcSEcCtD
Abiraterone—Infestation—Fluorouracil—head and neck cancer	0.000984	0.0114	CcSEcCtD
Abiraterone—Infestation NOS—Fluorouracil—head and neck cancer	0.000984	0.0114	CcSEcCtD
Abiraterone—Menopausal symptoms—Docetaxel—head and neck cancer	0.000977	0.0113	CcSEcCtD
Abiraterone—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000971	0.0112	CcSEcCtD
Abiraterone—Myocardial infarction—Fluorouracil—head and neck cancer	0.000965	0.0112	CcSEcCtD
Abiraterone—ALB—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00096	0.0133	CbGpPWpGaD
Abiraterone—Urinary tract infection—Fluorouracil—head and neck cancer	0.000957	0.0111	CcSEcCtD
Abiraterone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000948	0.0131	CbGpPWpGaD
Abiraterone—Cardiac failure—Docetaxel—head and neck cancer	0.000945	0.0109	CcSEcCtD
Abiraterone—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000911	0.0126	CbGpPWpGaD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000904	0.0105	CcSEcCtD
Abiraterone—Discomfort—Hydroxyurea—head and neck cancer	0.000899	0.0104	CcSEcCtD
Abiraterone—CYP17A1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000899	0.0124	CbGpPWpGaD
Abiraterone—Oedema—Hydroxyurea—head and neck cancer	0.000872	0.0101	CcSEcCtD
Abiraterone—Infection—Hydroxyurea—head and neck cancer	0.000867	0.01	CcSEcCtD
Abiraterone—Skin disorder—Hydroxyurea—head and neck cancer	0.000847	0.00981	CcSEcCtD
Abiraterone—CYP17A1—Biological oxidations—NAT2—head and neck cancer	0.000838	0.0116	CbGpPWpGaD
Abiraterone—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00083	0.00961	CcSEcCtD
Abiraterone—CYP17A1—Metapathway biotransformation—NAT2—head and neck cancer	0.000826	0.0114	CbGpPWpGaD
Abiraterone—Nasopharyngitis—Docetaxel—head and neck cancer	0.000825	0.00955	CcSEcCtD
Abiraterone—ABCC1—S1P1 pathway—PTGS2—head and neck cancer	0.00082	0.0113	CbGpPWpGaD
Abiraterone—Constipation—Vinblastine—head and neck cancer	0.000818	0.00947	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000813	0.00942	CcSEcCtD
Abiraterone—Arrhythmia—Fluorouracil—head and neck cancer	0.00079	0.00914	CcSEcCtD
Abiraterone—SULT2A1—Biological oxidations—GSTM1—head and neck cancer	0.00078	0.0108	CbGpPWpGaD
Abiraterone—Dyspnoea—Hydroxyurea—head and neck cancer	0.000778	0.00901	CcSEcCtD
Abiraterone—SULT2A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000769	0.0106	CbGpPWpGaD
Abiraterone—Dyspepsia—Hydroxyurea—head and neck cancer	0.000768	0.00889	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—BCL2—head and neck cancer	0.000763	0.0105	CbGpPWpGaD
Abiraterone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000753	0.00872	CcSEcCtD
Abiraterone—Fatigue—Hydroxyurea—head and neck cancer	0.000752	0.00871	CcSEcCtD
Abiraterone—Constipation—Hydroxyurea—head and neck cancer	0.000746	0.00864	CcSEcCtD
Abiraterone—SULT2A1—Biological oxidations—CYP1A1—head and neck cancer	0.000739	0.0102	CbGpPWpGaD
Abiraterone—CYP17A1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000738	0.0102	CbGpPWpGaD
Abiraterone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000735	0.0101	CbGpPWpGaD
Abiraterone—SULT2A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000729	0.0101	CbGpPWpGaD
Abiraterone—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.000723	0.00997	CbGpPWpGaD
Abiraterone—Pneumonia—Docetaxel—head and neck cancer	0.000715	0.00828	CcSEcCtD
Abiraterone—SULT2A1—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000713	0.00983	CbGpPWpGaD
Abiraterone—Anaemia—Fluorouracil—head and neck cancer	0.000711	0.00823	CcSEcCtD
Abiraterone—Infestation NOS—Docetaxel—head and neck cancer	0.000711	0.00823	CcSEcCtD
Abiraterone—Infestation—Docetaxel—head and neck cancer	0.000711	0.00823	CcSEcCtD
Abiraterone—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000709	0.00978	CbGpPWpGaD
Abiraterone—Acute coronary syndrome—Docetaxel—head and neck cancer	0.0007	0.00811	CcSEcCtD
Abiraterone—Myocardial infarction—Docetaxel—head and neck cancer	0.000697	0.00807	CcSEcCtD
Abiraterone—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000695	0.00959	CbGpPWpGaD
Abiraterone—Body temperature increased—Hydroxyurea—head and neck cancer	0.00069	0.00799	CcSEcCtD
Abiraterone—Asthenia—Vinblastine—head and neck cancer	0.000686	0.00795	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—IL2—head and neck cancer	0.000672	0.00927	CbGpPWpGaD
Abiraterone—Myalgia—Fluorouracil—head and neck cancer	0.000655	0.00758	CcSEcCtD
Abiraterone—Chest pain—Fluorouracil—head and neck cancer	0.000655	0.00758	CcSEcCtD
Abiraterone—Diarrhoea—Vinblastine—head and neck cancer	0.000654	0.00758	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—UROD—head and neck cancer	0.00065	0.00897	CbGpPWpGaD
Abiraterone—Discomfort—Fluorouracil—head and neck cancer	0.000647	0.00749	CcSEcCtD
Abiraterone—ABCC1—S1P1 pathway—VEGFA—head and neck cancer	0.000646	0.00891	CbGpPWpGaD
Abiraterone—ABCC1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000642	0.00886	CbGpPWpGaD
Abiraterone—ABCC1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000636	0.00877	CbGpPWpGaD
Abiraterone—Urinary tract disorder—Docetaxel—head and neck cancer	0.00063	0.00729	CcSEcCtD
Abiraterone—Oedema—Fluorouracil—head and neck cancer	0.000628	0.00727	CcSEcCtD
Abiraterone—Connective tissue disorder—Docetaxel—head and neck cancer	0.000627	0.00726	CcSEcCtD
Abiraterone—Asthenia—Hydroxyurea—head and neck cancer	0.000626	0.00725	CcSEcCtD
Abiraterone—Urethral disorder—Docetaxel—head and neck cancer	0.000625	0.00724	CcSEcCtD
Abiraterone—Infection—Fluorouracil—head and neck cancer	0.000624	0.00722	CcSEcCtD
Abiraterone—ABCC1—S1P1 pathway—MAPK3—head and neck cancer	0.000611	0.00843	CbGpPWpGaD
Abiraterone—Vomiting—Vinblastine—head and neck cancer	0.000608	0.00704	CcSEcCtD
Abiraterone—Diarrhoea—Hydroxyurea—head and neck cancer	0.000597	0.00691	CcSEcCtD
Abiraterone—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000593	0.00818	CbGpPWpGaD
Abiraterone—Cardiac disorder—Docetaxel—head and neck cancer	0.000592	0.00686	CcSEcCtD
Abiraterone—ABCC1—S1P1 pathway—MAPK1—head and neck cancer	0.000581	0.00802	CbGpPWpGaD
Abiraterone—Angiopathy—Docetaxel—head and neck cancer	0.000579	0.0067	CcSEcCtD
Abiraterone—Mediastinal disorder—Docetaxel—head and neck cancer	0.000575	0.00666	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000572	0.00662	CcSEcCtD
Abiraterone—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00057	0.00787	CbGpPWpGaD
Abiraterone—Arrhythmia—Docetaxel—head and neck cancer	0.00057	0.0066	CcSEcCtD
Abiraterone—Insomnia—Fluorouracil—head and neck cancer	0.000568	0.00658	CcSEcCtD
Abiraterone—Dyspnoea—Fluorouracil—head and neck cancer	0.00056	0.00648	CcSEcCtD
Abiraterone—Mental disorder—Docetaxel—head and neck cancer	0.000559	0.00647	CcSEcCtD
Abiraterone—Vomiting—Hydroxyurea—head and neck cancer	0.000555	0.00642	CcSEcCtD
Abiraterone—Dyspepsia—Fluorouracil—head and neck cancer	0.000553	0.0064	CcSEcCtD
Abiraterone—Rash—Hydroxyurea—head and neck cancer	0.00055	0.00637	CcSEcCtD
Abiraterone—Dermatitis—Hydroxyurea—head and neck cancer	0.00055	0.00636	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000542	0.00628	CcSEcCtD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—MAPK3—head and neck cancer	0.00054	0.00746	CbGpPWpGaD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—MAPK1—head and neck cancer	0.000514	0.00709	CbGpPWpGaD
Abiraterone—Anaemia—Docetaxel—head and neck cancer	0.000513	0.00594	CcSEcCtD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000504	0.00696	CbGpPWpGaD
Abiraterone—Body temperature increased—Fluorouracil—head and neck cancer	0.000496	0.00575	CcSEcCtD
Abiraterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000496	0.00684	CbGpPWpGaD
Abiraterone—Cough—Docetaxel—head and neck cancer	0.000485	0.00561	CcSEcCtD
Abiraterone—Hypertension—Docetaxel—head and neck cancer	0.000479	0.00555	CcSEcCtD
Abiraterone—Myalgia—Docetaxel—head and neck cancer	0.000473	0.00547	CcSEcCtD
Abiraterone—Chest pain—Docetaxel—head and neck cancer	0.000473	0.00547	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000469	0.00544	CcSEcCtD
Abiraterone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000464	0.0064	CbGpPWpGaD
Abiraterone—Oedema—Docetaxel—head and neck cancer	0.000453	0.00525	CcSEcCtD
Abiraterone—Infection—Docetaxel—head and neck cancer	0.00045	0.00521	CcSEcCtD
Abiraterone—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000445	0.00614	CbGpPWpGaD
Abiraterone—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000441	0.00608	CbGpPWpGaD
Abiraterone—Skin disorder—Docetaxel—head and neck cancer	0.00044	0.0051	CcSEcCtD
Abiraterone—Diarrhoea—Fluorouracil—head and neck cancer	0.00043	0.00497	CcSEcCtD
Abiraterone—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000422	0.00582	CbGpPWpGaD
Abiraterone—CYP17A1—Biological oxidations—GSTM1—head and neck cancer	0.000414	0.00571	CbGpPWpGaD
Abiraterone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000413	0.00478	CcSEcCtD
Abiraterone—Insomnia—Docetaxel—head and neck cancer	0.00041	0.00475	CcSEcCtD
Abiraterone—CYP17A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000408	0.00563	CbGpPWpGaD
Abiraterone—Dyspnoea—Docetaxel—head and neck cancer	0.000404	0.00468	CcSEcCtD
Abiraterone—Vomiting—Fluorouracil—head and neck cancer	0.000399	0.00462	CcSEcCtD
Abiraterone—Dyspepsia—Docetaxel—head and neck cancer	0.000399	0.00462	CcSEcCtD
Abiraterone—Rash—Fluorouracil—head and neck cancer	0.000396	0.00458	CcSEcCtD
Abiraterone—Dermatitis—Fluorouracil—head and neck cancer	0.000396	0.00458	CcSEcCtD
Abiraterone—CYP17A1—Biological oxidations—CYP1A1—head and neck cancer	0.000392	0.00541	CbGpPWpGaD
Abiraterone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000391	0.00453	CcSEcCtD
Abiraterone—Fatigue—Docetaxel—head and neck cancer	0.000391	0.00452	CcSEcCtD
Abiraterone—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000388	0.00535	CbGpPWpGaD
Abiraterone—Constipation—Docetaxel—head and neck cancer	0.000388	0.00449	CcSEcCtD
Abiraterone—CYP17A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000387	0.00534	CbGpPWpGaD
Abiraterone—ABCC1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000378	0.00522	CbGpPWpGaD
Abiraterone—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000373	0.00515	CbGpPWpGaD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—AKT1—head and neck cancer	0.000364	0.00503	CbGpPWpGaD
Abiraterone—ALB—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.00036	0.00496	CbGpPWpGaD
Abiraterone—Body temperature increased—Docetaxel—head and neck cancer	0.000358	0.00415	CcSEcCtD
Abiraterone—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000351	0.00484	CbGpPWpGaD
Abiraterone—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000347	0.00479	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—UROD—head and neck cancer	0.000345	0.00476	CbGpPWpGaD
Abiraterone—Asthenia—Docetaxel—head and neck cancer	0.000325	0.00377	CcSEcCtD
Abiraterone—Diarrhoea—Docetaxel—head and neck cancer	0.00031	0.00359	CcSEcCtD
Abiraterone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.0003	0.00414	CbGpPWpGaD
Abiraterone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000296	0.00409	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—SOD2—head and neck cancer	0.000293	0.00404	CbGpPWpGaD
Abiraterone—Vomiting—Docetaxel—head and neck cancer	0.000288	0.00334	CcSEcCtD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000287	0.00396	CbGpPWpGaD
Abiraterone—Rash—Docetaxel—head and neck cancer	0.000286	0.00331	CcSEcCtD
Abiraterone—Dermatitis—Docetaxel—head and neck cancer	0.000285	0.00331	CcSEcCtD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000284	0.00392	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—GPX1—head and neck cancer	0.000279	0.00385	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000276	0.00381	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000272	0.00376	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—NAT2—head and neck cancer	0.00027	0.00373	CbGpPWpGaD
Abiraterone—Testosterone—CYP1A1—head and neck cancer	0.000269	1	CrCbGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000268	0.00369	CbGpPWpGaD
Abiraterone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000246	0.0034	CbGpPWpGaD
Abiraterone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000243	0.00336	CbGpPWpGaD
Abiraterone—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000243	0.00335	CbGpPWpGaD
Abiraterone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	0.000243	0.00335	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—DPYD—head and neck cancer	0.000237	0.00327	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000233	0.00322	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000233	0.00321	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000227	0.00313	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—YAP1—head and neck cancer	0.000225	0.0031	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000223	0.00308	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000222	0.00306	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—UROD—head and neck cancer	0.000208	0.00287	CbGpPWpGaD
Abiraterone—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000206	0.00285	CbGpPWpGaD
Abiraterone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.0002	0.00276	CbGpPWpGaD
Abiraterone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000199	0.00275	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000169	0.00233	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000161	0.00223	CbGpPWpGaD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000161	0.00222	CbGpPWpGaD
Abiraterone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000159	0.00219	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—IL2—head and neck cancer	0.000152	0.0021	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000152	0.0021	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000151	0.00208	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000148	0.00204	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000147	0.00203	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000146	0.00202	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—NAT2—head and neck cancer	0.000143	0.00198	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000136	0.00188	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—TYMS—head and neck cancer	0.000135	0.00186	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000134	0.00185	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GSTM1—head and neck cancer	0.000133	0.00184	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000131	0.0018	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000131	0.0018	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000129	0.00178	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—GPX1—head and neck cancer	0.000128	0.00176	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000127	0.00176	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000127	0.00175	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CYP1A1—head and neck cancer	0.000126	0.00174	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—DPYD—head and neck cancer	0.000126	0.00173	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—YAP1—head and neck cancer	0.000119	0.00164	CbGpPWpGaD
Abiraterone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000114	0.00158	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—UROD—head and neck cancer	0.000114	0.00157	CbGpPWpGaD
Abiraterone—ALB—Metabolism—UROD—head and neck cancer	0.000113	0.00156	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000112	0.00154	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—VEGFA—head and neck cancer	0.000111	0.00153	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.00011	0.00152	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000106	0.00146	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000106	0.00146	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000105	0.00144	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000104	0.00143	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TP53—head and neck cancer	9.78e-05	0.00135	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—UROD—head and neck cancer	9.33e-05	0.00129	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.18e-05	0.00127	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.09e-05	0.00125	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.96e-05	0.00124	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.82e-05	0.00122	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.77e-05	0.00121	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NAT2—head and neck cancer	8.64e-05	0.00119	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.81e-05	0.00108	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—DPYD—head and neck cancer	7.58e-05	0.00105	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PTGS2—head and neck cancer	7.52e-05	0.00104	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	7.32e-05	0.00101	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	7.22e-05	0.000995	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—YAP1—head and neck cancer	7.19e-05	0.000992	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—TYMS—head and neck cancer	7.16e-05	0.000988	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSTM1—head and neck cancer	7.08e-05	0.000976	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	6.94e-05	0.000957	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	6.84e-05	0.000944	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GPX1—head and neck cancer	6.78e-05	0.000935	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP1A1—head and neck cancer	6.71e-05	0.000926	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PTEN—head and neck cancer	6.56e-05	0.000905	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—UROD—head and neck cancer	6.1e-05	0.000842	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	5.79e-05	0.000799	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.51e-05	0.00076	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.4e-05	0.000746	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.01e-05	0.000692	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.98e-05	0.000688	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.96e-05	0.000685	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.93e-05	0.000681	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	4.92e-05	0.000679	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NAT2—head and neck cancer	4.72e-05	0.000651	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.71e-05	0.00065	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NAT2—head and neck cancer	4.69e-05	0.000647	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	4.66e-05	0.000643	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PIK3CA—head and neck cancer	4.63e-05	0.000638	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	4.43e-05	0.000612	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—TYMS—head and neck cancer	4.32e-05	0.000596	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTM1—head and neck cancer	4.27e-05	0.000589	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—DPYD—head and neck cancer	4.14e-05	0.000571	CbGpPWpGaD
Abiraterone—ALB—Metabolism—DPYD—head and neck cancer	4.11e-05	0.000568	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GPX1—head and neck cancer	4.09e-05	0.000564	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP1A1—head and neck cancer	4.05e-05	0.000558	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTGS2—head and neck cancer	3.99e-05	0.00055	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—YAP1—head and neck cancer	3.93e-05	0.000542	CbGpPWpGaD
Abiraterone—ALB—Metabolism—YAP1—head and neck cancer	3.9e-05	0.000539	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NAT2—head and neck cancer	3.87e-05	0.000535	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOTCH1—head and neck cancer	3.87e-05	0.000534	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	3.85e-05	0.000531	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKT1—head and neck cancer	3.78e-05	0.000521	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTEN—head and neck cancer	3.48e-05	0.00048	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—DPYD—head and neck cancer	3.4e-05	0.000469	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.32e-05	0.000459	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—YAP1—head and neck cancer	3.22e-05	0.000445	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	3.14e-05	0.000434	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IL2—head and neck cancer	2.99e-05	0.000412	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.95e-05	0.000407	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.93e-05	0.000405	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTGS2—head and neck cancer	2.87e-05	0.000396	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.57e-05	0.000355	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.56e-05	0.000353	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—head and neck cancer	2.54e-05	0.00035	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NAT2—head and neck cancer	2.53e-05	0.00035	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTEN—head and neck cancer	2.51e-05	0.000346	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CA—head and neck cancer	2.45e-05	0.000339	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS2—head and neck cancer	2.41e-05	0.000332	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK3—head and neck cancer	2.4e-05	0.000331	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TYMS—head and neck cancer	2.36e-05	0.000325	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TYMS—head and neck cancer	2.34e-05	0.000323	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—head and neck cancer	2.33e-05	0.000322	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—head and neck cancer	2.32e-05	0.00032	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK1—head and neck cancer	2.28e-05	0.000315	CbGpPWpGaD
Abiraterone—ABCC1—Disease—STAT3—head and neck cancer	2.24e-05	0.000309	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GPX1—head and neck cancer	2.23e-05	0.000308	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—DPYD—head and neck cancer	2.22e-05	0.000306	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GPX1—head and neck cancer	2.22e-05	0.000306	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1A1—head and neck cancer	2.21e-05	0.000305	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1A1—head and neck cancer	2.2e-05	0.000303	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK3—head and neck cancer	2.14e-05	0.000295	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—YAP1—head and neck cancer	2.11e-05	0.000291	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTEN—head and neck cancer	2.1e-05	0.00029	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK1—head and neck cancer	2.04e-05	0.000281	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EGFR—head and neck cancer	2.04e-05	0.000281	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—head and neck cancer	2e-05	0.000277	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CA—head and neck cancer	1.98e-05	0.000274	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TYMS—head and neck cancer	1.94e-05	0.000267	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—head and neck cancer	1.92e-05	0.000265	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.91e-05	0.000264	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HRAS—head and neck cancer	1.83e-05	0.000253	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GPX1—head and neck cancer	1.83e-05	0.000253	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.82e-05	0.00025	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.81e-05	0.00025	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.8e-05	0.000249	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CA—head and neck cancer	1.77e-05	0.000244	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HRAS—head and neck cancer	1.64e-05	0.000226	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—head and neck cancer	1.62e-05	0.000223	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CA—head and neck cancer	1.48e-05	0.000204	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—head and neck cancer	1.44e-05	0.000199	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.31e-05	0.000181	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS2—head and neck cancer	1.31e-05	0.00018	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TYMS—head and neck cancer	1.27e-05	0.000175	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.25e-05	0.000173	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—head and neck cancer	1.21e-05	0.000167	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GPX1—head and neck cancer	1.2e-05	0.000165	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.19e-05	0.000164	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTEN—head and neck cancer	1.15e-05	0.000158	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTEN—head and neck cancer	1.14e-05	0.000157	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.08e-05	0.000149	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTEN—head and neck cancer	9.41e-06	0.00013	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CA—head and neck cancer	8.08e-06	0.000112	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CA—head and neck cancer	8.04e-06	0.000111	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.05e-06	9.73e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CA—head and neck cancer	6.64e-06	9.16e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—head and neck cancer	6.6e-06	9.11e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—head and neck cancer	6.57e-06	9.06e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTEN—head and neck cancer	6.15e-06	8.49e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—head and neck cancer	5.42e-06	7.48e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.34e-06	5.99e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—head and neck cancer	3.54e-06	4.89e-05	CbGpPWpGaD
